Invention Grant
- Patent Title: Azaindoles as Janus kinase inhibitors
- Patent Title (中): Azaindoles作为Janus激酶抑制剂
-
Application No.: US14349377Application Date: 2012-09-28
-
Publication No.: US09096598B2Publication Date: 2015-08-04
- Inventor: John W. Butcher , David Witter , Christopher Dinsmore , June Kim , John Hendrix , Raksha Archarya , Sean P. Ahearn , Joon Jung , Alexey Rivkin , Philip Jones
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Patricia A. Shatynski; Catherine D. Fitch
- International Application: PCT/US2012/057695 WO 20120928
- International Announcement: WO2013/052355 WO 20130411
- Main IPC: C07D401/10
- IPC: C07D401/10 ; A61K31/437 ; C07D471/04 ; C07D519/00
Abstract:
The instant invention provides compounds of formula I which are JAK inhibitors, and as such are useful for the treatment of JAK-mediated diseases such as rheumatoid arthritis, asthma, COPD and cancer.
Public/Granted literature
- US20140303142A1 AZAINDOLES AS JANUS KINASE INHIBITORS Public/Granted day:2014-10-09
Information query
